Amanote Research

Amanote Research

    RegisterSign In

The Good, the Bad, and the Ugly: Hyperprogression in Cancer Patients Following Immune Checkpoint Therapy

Genome Medicine - United Kingdom
doi 10.1186/s13073-019-0661-7
Full Text
Open PDF
Abstract

Available in full text

Categories
Molecular MedicineGeneticsMolecular Biology
Date

July 24, 2019

Authors
Erich SabioTimothy A. Chan
Publisher

Springer Science and Business Media LLC


Related search

Sun, Melanin, and Cancer: The Good, the Bad, and the Ugly

Revista Virtual de Quimica
MathematicsChemistry
2015English

TRP Channels in Prostate Cancer: The Good, the Bad and the Ugly?

Asian Journal of Andrology
MedicineUrology
2011English

Meetings—The Good, the Bad, and the Ugly

AAOHN Journal
2011English

Good, Bad, Ugly

Chemical and Engineering News
Chemical Engineering
2013English

Managing ETDs: The Good, the Bad, and the Ugly

2018English

Nonlinear Optics: The Good, Bad, Ugly, Beautiful

2015English

The Good, the Bad, and the Ugly in the Melting Pot

Equality, Diversity and Inclusion
SociologyOrganizational BehaviorHuman Resource ManagementGender StudiesCultural StudiesPolitical Science
2017English

Cardiovascular Effects of the Incretin-Based Therapy: The Good, the Bad, or the Ugly?

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2015English

Polio Vaccination in Nigeria: The ?Good?, the ?Bad? And the ?Ugly?

Journal of Antivirals & Antiretrovirals
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy